Cancer chemoprevention involves the use of synthetic and biologic agents as targeted therapies for disease prevention, reduction, or suppression. Mechanisms of blocking or suppressing cancer-related pathways include processes of carcinogenesis, chronic inflammatory responses, DNA modulation, and...

Background: Cancer-related infections lead to increases in mortality, antibiotic use, and hospital stays. Other adverse outcomes include dose delays and reductions, which can result in suboptimal treatment outcomes. Objectives: Effective implementation of risk assessment and evidence-based...

Background: A common class-specific toxicity of mammalian target of rapamycin (mTOR) inhibitors is stomatitis. Some patients experience a severe form of mTOR inhibitor–associated stomatitis (mIAS) that can have a negative effect on nutritional status, compromise quality of life, and potentially...

Background: Human papillomavirus (HPV) vaccines have the potential to reduce Korean American women’s high burden of cervical cancer, but information is limited about their awareness of HPV and its vaccine. Objectives: This study aimed to explore Korean American female college students’ awareness of...